Podcast Episodes
Back to SearchAccelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.
We love to hear from our listeners. Send us a message.
Mythic Therapeutics Chief Scientific Officer and co-founder Brian Fiske, Ph.D. broke some unwr…
1 year, 10 months ago
The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch
We love to hear from our listeners. Send us a message.
This isn't your typical drug sponsor + CDMO story. In fact, CTMC's Jason Bock, Ph.D. says you …
1 year, 11 months ago
A New Prescription For PBMs with Allan Shaw
We love to hear from our listeners. Send us a message.
Back by popular demand, biopharma industry opinionator extraordinaire Allan Shaw rejoins the B…
1 year, 11 months ago
New Apps For AI in mRNA With Anima Biotech's Yochi Slonim
We love to hear from our listeners. Send us a message.
From San Francisco’s Silicon Valley to Tel Aviv’s Silicon Wadi, software business entrepreneur…
1 year, 11 months ago
Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch
We love to hear from our listeners. Send us a message.
As if Orna Therapeutics' CEO Thomas Barnes, CEO isn't a enough to draw you in to the Business …
1 year, 11 months ago
Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.
We love to hear from our listeners. Send us a message.
Novel technologies aren’t interesting to Rahul Kakkar, M.D. unless they help patients. Sounds …
1 year, 11 months ago
Commercial Readiness with ImmunityBio's Bobby Reddy, M.D.
We love to hear from our listeners. Send us a message.
This episode of the Business of Biotech begins with a personal story about my dad and the stan…
2 years ago
Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, D.Phil.
We love to hear from our listeners. Send us a message.
Ampersand Biomedicines CEO Jason Gardner, D.Phil. first took the leap from a global pharmaceut…
2 years ago
Funding Alzheimer's Tx Dev with ADDF's Karen Harris
We love to hear from our listeners. Send us a message.
We've really been looking forward to dropping this episode with Karen Harris, Chief Financial …
2 years ago
The AI Impact with Generate:Biomedicines' Mike Nally
We love to hear from our listeners. Send us a message.
Few drug discovery and development concepts are as hyped, and as such, draw as much polarity f…
2 years ago